AIG
KYMR icon

American International Group’s Kymera Therapeutics KYMR Stock Holding History

American International Group’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,095
Closed -$808K – 1450
2024
Q1 		$808K Buy
20,095
+1,209
+6% +$43.3K ﹤0.01% 1411
2023
Q4 		$481K Sell
18,886
-76
-0.4% -$1.36K ﹤0.01% 1682
2023
Q3 		$264K Buy
18,962
+674
+4% +$13.6K ﹤0.01% 1970
2023
Q2 		$420K Buy
18,288
+39
+0.2% +$1.12K ﹤0.01% 1759
2023
Q1 		$541K Buy
18,249
+363
+2% +$11.7K ﹤0.01% 1556
2022
Q4 		$446K Sell
17,886
-65
-0.4% -$1.73K ﹤0.01% 1655
2022
Q3 		$391K Buy
17,951
+253
+1% +$6.67K ﹤0.01% 1728
2022
Q2 		$348K Buy
17,698
+638
+4% +$14.9K ﹤0.01% 1828
2022
Q1 		$722K Sell
17,060
-1,201
-7% -$50.7K ﹤0.01% 1516
2021
Q4 		$1.16M Sell
18,261
-546
-3% -$31.8K 0.01% 1334
2021
Q3 		$1.1M Buy
18,807
+2,609
+16% +$151K 0.01% 1389
2021
Q2 		$786K Buy
16,198
+10,321
+176% +$448K ﹤0.01% 1647
2021
Q1 		$228K Buy
5,877
+16
+0.3% +$963 ﹤0.01% 2300
2020
Q4 		$363K Buy
+5,861
New +$286K ﹤0.01% 1931

Other funds holding KYMR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

American International Group's KYMR Position: Q2 2024 in Review

American International Group sold out of Kymera Therapeutics (KYMR) in Q2 2024, closing a stake of 20,095 shares — an estimated $808K sold.

American International Group first reported a position in KYMR in Q4 2020 and held it in 14 quarters. The position peaked at $1.16M in Q4 2021. 157 funds tracked by Wall St. Rank hold KYMR as of Q2 2024.

  • American International Group reported no remaining Kymera Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 20,095 Kymera Therapeutics shares in Q2 2024, an estimated $808K.
  • American International Group first reported a position in Kymera Therapeutics in Q4 2020 and held it in 14 quarters.
  • American International Group's Kymera Therapeutics position peaked at $1.16M in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.